Skip to main content
    G

    Greenwich Lifesciences Inc (GLSI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $13.76
    -1.18 (-7.90%)

    Market Cap: $219.29M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Greenwich Lifesciences Inc (GLSI) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Greenwich Lifesciences are Galectin Therapeutics (GALT), Lineage Cell Therapeutics (LCTX) and Palisade Bio (PALI). By market cap, Greenwich Lifesciences ranks 6th of the 13 companies on this page; Galectin Therapeutics (GALT) is the largest at $307.59M.

    Peer Comparison

    GLSI's revenue growth of 0.0% is above the peer median of -30.5%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Greenwich Lifesciences (GLSI)$219.29MN/AN/A0.0%N/A0.0%0.00%
    Galectin Therapeutics Inc (GALT)$307.59MN/AN/A0.0%671.1%0.0%0.00%
    Lineage Cell Therapeutics Inc (LCTX)$231.35MN/A18.7x16.2%-6.7%-61.0%0.00%
    Palisade Bio Inc (PALI)$201.01MN/A436.8x0.0%N/A0.0%0.00%
    Zentalis Pharmaceuticals Llc (ZNTL)$167.05MN/AN/A0.0%N/A0.0%0.00%
    Sol Gel Technologies Ltd (SLGL)$180.46MN/A125.4x0.0%N/A-96.6%0.00%
    Century Therapeutics Inc (IPSC)$299.63MN/AN/A0.0%N/A-100.0%0.00%
    SAB Biotherapeutics Inc (SABS)$266.66MN/AN/A0.0%N/A-62.4%0.00%
    Nautilus Biotechnology Inc (NAUT)$295.50MN/A630.2x0.0%N/A0.0%0.00%
    Pyxis Oncology Inc (PYXS)$188.98MN/A11.6x0.0%N/A0.0%0.00%
    Compass Therapeutics Inc. (CMPX)$139.35MN/AN/A0.0%N/A0.0%0.00%
    MacroGenics Inc (MGNX)$140.60MN/A1.2x-36.6%-108.7%-64.8%0.00%
    Cellectis SA (CLLS)$118.86MN/A1.8x0.0%-74.1%-85.4%0.00%
    Peer median$195.00MN/A18.7x0.0%-40.4%-30.5%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Greenwich Lifesciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Galectin Therapeutics Inc (GALT)
    Galectin Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of therapies for fibrotic...
    GALT competitors
    Lineage Cell Therapeutics Inc (LCTX)
    Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapeutics for the treatment...
    LCTX competitors
    Palisade Bio Inc (PALI)
    Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier.
    PALI competitors
    Zentalis Pharmaceuticals Llc (ZNTL)
    Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapies for the treatment...
    ZNTL competitors
    Sol Gel Technologies Ltd (SLGL)
    Sol-Gel Technologies Ltd., a specialty clinical-stage pharmaceutical company, is focused on developing and commercializing topical dermatological...
    SLGL competitors
    Century Therapeutics Inc (IPSC)
    Century Therapeutics Inc. (Ticker: IPSC) is a leading biotechnology company specializing in allogenic cell therapy...
    IPSC competitors
    SAB Biotherapeutics Inc (SABS)
    SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology.
    SABS competitors
    Nautilus Biotechnology Inc (NAUT)
    Nautilus Biotechnology, Inc., a development-stage life sciences company, is dedicated to creating platform technology to quantify and unlock proteome...
    NAUT competitors
    Pyxis Oncology Inc (PYXS)
    Pyxis Oncology, Inc., a preclinical biotechnology company, is dedicated to developing antibody-drug conjugate (ADC) and monoclonal antibody (mAb)...
    PYXS competitors
    Compass Therapeutics Inc. (CMPX)
    Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple...
    CMPX competitors
    MacroGenics Inc (MGNX)
    MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States.
    MGNX competitors
    Cellectis SA (CLLS)
    Cellectis SA, a clinical-stage biotechnology company, develops immuno-oncology products based on gene-edited T cells that express chimeric antigen receptors...
    CLLS competitors

    Frequently Asked Questions About GLSI

    Who are Greenwich Lifesciences' main competitors?

    The companies most similar to Greenwich Lifesciences include Galectin Therapeutics (GALT), Lineage Cell Therapeutics (LCTX), Palisade Bio (PALI), Zentalis Pharmaceuticals Llc (ZNTL) and Sol Gel Technologies (SLGL), listed from the closest match.

    Who is Greenwich Lifesciences' biggest competitor?

    Galectin Therapeutics (GALT) is both the largest of the similar companies at $307.59M and the closest match by business profile, size, sector and industry.

    How does GLSI stock compare with its competitors?

    GLSI's net margin is 0.0% against a peer median of 0.0%.

    Which of Greenwich Lifesciences' competitors pays a higher dividend?

    Greenwich Lifesciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Greenwich Lifesciences bigger than its competitors?

    No. Greenwich Lifesciences is 6th by market cap among the 13 companies on this page; the largest is Galectin Therapeutics (GALT) at $307.59M.